<p>(<b>A, B</b>) Left: Percentage of annexin V/PI positive cells 5 or 13 d after treatment with either γIR (3.5 Gy), CQ (5 µM) or PI-103 (0.5 µM) alone, with double or triple combinations. Right: cell numbers after trypan blue staining. Lower panel in A: flow cytometry data showing that cell death occurred primarily through apoptosis. (<b>C</b>) Western blot analysis of LC3-I/II conversion and of p21 expression levels.</p
<p>(A) Analysis of early apoptotic cells and (B) late apoptotic cells by annexin V binding and propi...
<p>The cells were divided into four groups as described before (A: 0Gy + 0ng/ml Sema3a; B: 0Gy + 50n...
<p>(A) Flow cytometry scatter plot after Annexin V-FITC/PI staining: left lower quadrant: normal cel...
<p>(<b>A</b>) Upper panel: percentage of annexin V/PI positive cells 5 d after treatment with CQ alo...
<p>(<b>A</b>) Percentage of annexin V/PI positive cells 5 d after treatment with 10 Gy, a PI3K/Akt p...
<p>(<b>A</b>–C) Percentage of annexin V/PI positive cells 2, 4, or 6 d after irradiation with 0, 2, ...
<p>(A) Western blot analysis of apoptosis markers of GBM cells following treatment with increasing c...
<p>After treatment with <b>41</b> and GDC0941 (5 or 10 µM) for 24 h, PC3 cells were harvested and de...
(A) Microscopic analysis of live cells following treatment with Slc3a2 siRNA or scrambled control. (...
<p>(A) Dose-dependent effects of TQ and DG detected by cell cycle–based apoptosis assay. Cells were ...
<p>(A) Early apoptosis detection was measured by flow cytometry with an Annexin V apoptosis detectio...
<p>ESCs were maintained in control conditions (with LIF), in the absence of LIF (differentiation con...
<p>(<b>A–D</b>) BV173 cells and K562 cells were treated with 0, 5 mM, 10 mM, 15 mM HP-β-CyD, respect...
<p>(A) Representative histograms depicting apoptosis of MKN-28 cells transiently transfected with 10...
<p>Untreated cells (A); cilengitide treated cells (B); RGDechi-hCit treated cells (C). Upper left qu...
<p>(A) Analysis of early apoptotic cells and (B) late apoptotic cells by annexin V binding and propi...
<p>The cells were divided into four groups as described before (A: 0Gy + 0ng/ml Sema3a; B: 0Gy + 50n...
<p>(A) Flow cytometry scatter plot after Annexin V-FITC/PI staining: left lower quadrant: normal cel...
<p>(<b>A</b>) Upper panel: percentage of annexin V/PI positive cells 5 d after treatment with CQ alo...
<p>(<b>A</b>) Percentage of annexin V/PI positive cells 5 d after treatment with 10 Gy, a PI3K/Akt p...
<p>(<b>A</b>–C) Percentage of annexin V/PI positive cells 2, 4, or 6 d after irradiation with 0, 2, ...
<p>(A) Western blot analysis of apoptosis markers of GBM cells following treatment with increasing c...
<p>After treatment with <b>41</b> and GDC0941 (5 or 10 µM) for 24 h, PC3 cells were harvested and de...
(A) Microscopic analysis of live cells following treatment with Slc3a2 siRNA or scrambled control. (...
<p>(A) Dose-dependent effects of TQ and DG detected by cell cycle–based apoptosis assay. Cells were ...
<p>(A) Early apoptosis detection was measured by flow cytometry with an Annexin V apoptosis detectio...
<p>ESCs were maintained in control conditions (with LIF), in the absence of LIF (differentiation con...
<p>(<b>A–D</b>) BV173 cells and K562 cells were treated with 0, 5 mM, 10 mM, 15 mM HP-β-CyD, respect...
<p>(A) Representative histograms depicting apoptosis of MKN-28 cells transiently transfected with 10...
<p>Untreated cells (A); cilengitide treated cells (B); RGDechi-hCit treated cells (C). Upper left qu...
<p>(A) Analysis of early apoptotic cells and (B) late apoptotic cells by annexin V binding and propi...
<p>The cells were divided into four groups as described before (A: 0Gy + 0ng/ml Sema3a; B: 0Gy + 50n...
<p>(A) Flow cytometry scatter plot after Annexin V-FITC/PI staining: left lower quadrant: normal cel...